PressureStim is the only known system under evaluation designed to control release of proteins which improve elasticity of the aorta and other peripheral vessels so that the blood pressure has a dampening relief system within the body as is found in normal healthy subjects.
Leonhardt’s Launchpads Accelerator To Showcase Eight Innovation Assets and Startups At 2022 Demo Day
Irvine, Calif., Nov. 16th, 2021 /PRDistribution/ -- Leonhardt's Launchpads announced today that they will showcase eight graduates of their innovation and startup launch accelerator program on a Demo Day. The event will occur both in person and virtually on Friday,...read more
PressureStim is designed to lower high blood pressure by improving elastic compliance of the aorta and other arteries and bioelectric potentials balance management throughout the body. Santa Monica, CA and Salt Lake City, Utah (PRBUZZ) – Today the team at Leonhardt’s...read more
PRESSURESTIM A LEONHARDT VENTURES CO. ANNOUNCES LICENSING OF PATENT PORTFOLIO FOR BIOELECTRIC BLOOD PRESSURE MANAGEMENT FROM NEURO CODE TECH HOLDINGS LLC EXPANDING ITS INTELLECTUAL PROPERTY ESTATE.
Press Release – Santa Monica, California and Albuquerque, New Mexico, September 22nd, 2017 – PressureStim, an emerging leader in bioelectric blood pressure management announced today that the Company has entered into an option agreement that leads to an exclusive...read more